Erythema annulare centrifugum-type eruption in a patient undergoing cancer vaccine immunotherapy
If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2018-10-15
Language
American English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Dermatology Online Journal
Abstract
Sipuleucel-T is a cellular immunotherapy approved for the treatment of metastatic castration-resistant prostate cancer. We report a patient developing an immune related adverse effect from sipuleucel-T drug-induced erythema annulare centrifugum-like eruption. A brief review of the mechanism and implications of this eruption are also included.
Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Tadros, J., & Rahnama-Moghadam, S. (2018). Erythema annulare centrifugum-type eruption in a patient undergoing cancer vaccine immunotherapy. Dermatology Online Journal, 24(10).
ISSN
1087-2108
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Source
Publisher
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
Version
Final published version